ZA99105B - Method for administering monomeric insulin analogs. - Google Patents
Method for administering monomeric insulin analogs.Info
- Publication number
- ZA99105B ZA99105B ZA9900105A ZA99105A ZA99105B ZA 99105 B ZA99105 B ZA 99105B ZA 9900105 A ZA9900105 A ZA 9900105A ZA 99105 A ZA99105 A ZA 99105A ZA 99105 B ZA99105 B ZA 99105B
- Authority
- ZA
- South Africa
- Prior art keywords
- insulin analogs
- monomeric insulin
- administering monomeric
- administering
- analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7075298P | 1998-01-08 | 1998-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA99105B true ZA99105B (en) | 2000-07-07 |
Family
ID=22097181
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9900105A ZA99105B (en) | 1998-01-08 | 1999-01-07 | Method for administering monomeric insulin analogs. |
ZA9900104A ZA99104B (en) | 1998-01-08 | 1999-01-07 | Method for administering ASPB28-human insulin. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9900104A ZA99104B (en) | 1998-01-08 | 1999-01-07 | Method for administering ASPB28-human insulin. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20010007853A1 (ru) |
EP (2) | EP0951910A3 (ru) |
JP (2) | JP2002500193A (ru) |
KR (2) | KR20010033941A (ru) |
CN (2) | CN1287492A (ru) |
AU (2) | AU747619B2 (ru) |
BR (2) | BR9906796A (ru) |
CA (2) | CA2317733A1 (ru) |
EA (2) | EA200000748A1 (ru) |
HU (2) | HUP0100391A3 (ru) |
IL (2) | IL137105A0 (ru) |
NO (2) | NO20003050D0 (ru) |
PL (2) | PL342745A1 (ru) |
TR (2) | TR200001892T2 (ru) |
WO (2) | WO1999034816A1 (ru) |
ZA (2) | ZA99105B (ru) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
US6858199B1 (en) * | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
EP1196445A1 (en) * | 1999-06-29 | 2002-04-17 | Eli Lilly And Company | Insulin crystals for pulmonary administration |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
US7374782B2 (en) | 2000-10-27 | 2008-05-20 | Baxter International Inc. | Production of microspheres |
EP1944016A1 (en) | 2001-08-16 | 2008-07-16 | Baxter International Inc. | Propellant-based microparticle formulatons |
PT1418890E (pt) * | 2001-08-16 | 2008-06-09 | Baxter Int | Formulações de micropartículas à base de propulsor |
WO2003047553A1 (en) * | 2001-12-07 | 2003-06-12 | Eiffel Technologies Limited | Synthesis of small particles |
AU2002359730A1 (en) * | 2001-12-21 | 2003-07-30 | Smithkline Beecham Corporation | Compositions and methods for altering glucose production |
US7677411B2 (en) | 2002-05-10 | 2010-03-16 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders |
US6985798B2 (en) * | 2002-05-10 | 2006-01-10 | Oriel Therapeutics, Inc. | Dry powder dose filling systems and related methods |
WO2004002395A2 (en) * | 2002-06-27 | 2004-01-08 | Oriel Therapeutics, Inc. | Apparatus, systems and related methods for processing, dispensing and/or evaluating non-pharmaceutical dry powders |
US7451761B2 (en) * | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US7377277B2 (en) * | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
WO2005041848A2 (en) | 2003-10-27 | 2005-05-12 | Oriel Therapeutics, Inc. | Dry powder drug containment system packages with tabs, inhalers and associated methods |
WO2005065756A2 (en) | 2003-12-30 | 2005-07-21 | Oriel Therapeutics, Inc. | Dry powder nebulizers and associated methods of dispensing dry powders |
US7624733B2 (en) | 2004-02-09 | 2009-12-01 | Oriel Therapeutics, Inc. | Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances |
CA2616997C (en) | 2004-09-13 | 2014-12-23 | Oriel Therapeutics, Inc. | Dry powder inhalers that inhibit agglomeration, related devices and methods |
JP5108764B2 (ja) * | 2005-08-25 | 2012-12-26 | オリエル・セラピューティクス,インコーポレイテッド | 薬剤格納システムを備えたスティック、並びに関連するキット、乾燥粉末吸入器および方法 |
AU2007210177C1 (en) | 2006-01-31 | 2012-11-01 | Oriel Therapeutics, Inc. | Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods |
EP2060268A1 (en) * | 2007-11-15 | 2009-05-20 | Novo Nordisk A/S | Pharmaceutical compositions for pulmonary or nasal delivery of peptides |
US8887722B2 (en) * | 2008-09-26 | 2014-11-18 | Oriel Therapeutics, Inc. | Inhaler mechanisms with radially biased piercers and related methods |
BRPI0919126B1 (pt) * | 2008-09-26 | 2021-07-27 | Oriel Therapeutics, Inc | Inalador de pó seco |
KR101311977B1 (ko) | 2008-09-26 | 2013-09-26 | 오리엘 테라퓨틱스, 인크. | 분리된 공기통로 채널들을 갖는 공기통로 디스크들 및 관련된 디스크들을 구비한 흡입기 및 이와 관련된 방법 |
US9050427B2 (en) * | 2008-09-30 | 2015-06-09 | Oriel Therapeutics, Inc. | Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods |
US8991391B2 (en) * | 2008-09-30 | 2015-03-31 | Oriel Therapeutics, Inc. | Dry powder inhalers with endless strips and cooperating piercers and related methods |
MX2011003245A (es) * | 2008-10-01 | 2011-04-26 | Oriel Therapeutics Inc | Inhaladores de polvo seco con mecanismos de perforacion giratorios y dispositivos y metodos relacionados. |
JP5341532B2 (ja) * | 2009-01-19 | 2013-11-13 | 第一電子工業株式会社 | 1対の誤嵌合防止キー及び該キーを用いた電気コネクタ |
CN101912600B (zh) * | 2010-01-11 | 2014-01-29 | 杨国汉 | 改善胰岛素在溶液中稳定性的方法 |
US9056173B2 (en) | 2010-01-27 | 2015-06-16 | Aespira Ltd. | Dry powder inhaler |
USD635246S1 (en) | 2010-03-26 | 2011-03-29 | Oriel Therapeutics, Inc. | Dose disk for dry powder inhalers |
USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
US10238820B2 (en) | 2014-01-08 | 2019-03-26 | Seroton, Inc. | Dry-powder inhalation device |
US11491288B2 (en) | 2014-01-08 | 2022-11-08 | Seroton, Inc. | Dispenser for dry-powder inhalation devices |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK179286D0 (da) * | 1986-04-18 | 1986-04-18 | Nordisk Gentofte | Insulinpraeparat |
PT93057B (pt) * | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
US5230884A (en) * | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
DK72793D0 (da) * | 1993-06-21 | 1993-06-21 | Novo Nordisk As | Nyt produkt |
JP2837956B2 (ja) * | 1993-06-21 | 1998-12-16 | ノボ ノルディスク アクティーゼルスカブ | Asp▲上B28▼インスリン結晶 |
TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5451569A (en) * | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
US5461031A (en) * | 1994-06-16 | 1995-10-24 | Eli Lilly And Company | Monomeric insulin analog formulations |
US5547929A (en) * | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
AR002976A1 (es) * | 1995-03-31 | 1998-05-27 | Lilly Co Eli | Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas |
AU5724996A (en) * | 1995-05-05 | 1996-11-21 | Eli Lilly And Company | Single chain insulin with high bioactivity |
-
1999
- 1999-01-06 US US09/226,420 patent/US20010007853A1/en not_active Abandoned
- 1999-01-06 US US09/226,412 patent/US20010053761A1/en not_active Abandoned
- 1999-01-07 IL IL13710599A patent/IL137105A0/xx unknown
- 1999-01-07 WO PCT/US1999/000324 patent/WO1999034816A1/en not_active Application Discontinuation
- 1999-01-07 IL IL13715099A patent/IL137150A0/xx unknown
- 1999-01-07 EA EA200000748A patent/EA200000748A1/ru unknown
- 1999-01-07 HU HU0100391A patent/HUP0100391A3/hu unknown
- 1999-01-07 PL PL99342745A patent/PL342745A1/xx not_active Application Discontinuation
- 1999-01-07 EP EP99300111A patent/EP0951910A3/en not_active Withdrawn
- 1999-01-07 BR BR9906796-0A patent/BR9906796A/pt not_active Application Discontinuation
- 1999-01-07 TR TR2000/01892T patent/TR200001892T2/xx unknown
- 1999-01-07 KR KR1020007007525A patent/KR20010033941A/ko not_active Application Discontinuation
- 1999-01-07 AU AU23122/99A patent/AU747619B2/en not_active Ceased
- 1999-01-07 CA CA002317733A patent/CA2317733A1/en not_active Abandoned
- 1999-01-07 TR TR2000/01891T patent/TR200001891T2/xx unknown
- 1999-01-07 AU AU21073/99A patent/AU754707B2/en not_active Ceased
- 1999-01-07 EP EP99300122A patent/EP0951911A3/en not_active Withdrawn
- 1999-01-07 CA CA002317739A patent/CA2317739A1/en not_active Abandoned
- 1999-01-07 CN CN99802020A patent/CN1287492A/zh active Pending
- 1999-01-07 KR KR1020007007524A patent/KR20010033940A/ko not_active Application Discontinuation
- 1999-01-07 WO PCT/US1999/000290 patent/WO1999034815A1/en not_active Application Discontinuation
- 1999-01-07 PL PL99341592A patent/PL341592A1/xx not_active Application Discontinuation
- 1999-01-07 ZA ZA9900105A patent/ZA99105B/xx unknown
- 1999-01-07 BR BR9906813-3A patent/BR9906813A/pt not_active IP Right Cessation
- 1999-01-07 HU HU0101293A patent/HUP0101293A3/hu unknown
- 1999-01-07 JP JP2000527264A patent/JP2002500193A/ja not_active Withdrawn
- 1999-01-07 CN CNB998020192A patent/CN1195543C/zh not_active Expired - Fee Related
- 1999-01-07 EA EA200000747A patent/EA200000747A1/ru unknown
- 1999-01-07 JP JP2000527263A patent/JP2002500192A/ja not_active Withdrawn
- 1999-01-07 ZA ZA9900104A patent/ZA99104B/xx unknown
-
2000
- 2000-06-14 NO NO20003050A patent/NO20003050D0/no not_active Application Discontinuation
- 2000-06-14 NO NO20003051A patent/NO20003051L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA99105B (en) | Method for administering monomeric insulin analogs. | |
ZA989744B (en) | Method for administering acylated insulin. | |
EP0813428A4 (en) | CONE INFUSION PUMP FOR AT LEAST ONE SYRINGE | |
HK1030753A1 (en) | Fracture healing using pthrp analogs. | |
PL346317A1 (en) | Method for administering insulinotropic peptides | |
ZA98361B (en) | Hypodermic injection system. | |
ZA984697B (en) | Stable insulin formulations. | |
ZA962933B (en) | Lactacystin analogs. | |
HUP0200556A2 (en) | Medicament for treating diabetes | |
AU3068599A (en) | Medication infusion set | |
TW373505U (en) | Improved structure for the safety syringe barrel | |
HK1018464A1 (en) | Improved process for obtaining insulin precursors having correctly bonded cystine bridges. | |
ZA200006116B (en) | Distillation process for easily polymerizable substance-containing solution. | |
HUP0204109A3 (en) | Oral preparations for diabetes | |
ZA200202521B (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preprations containing said compounds. | |
ZA99283B (en) | Inhaler for medication. | |
HUP0103852A3 (en) | Container for intravenous administration | |
EG23909A (en) | Vatamin d, analogs | |
HUP0102842A3 (en) | Pharmaceutical composition for injection based on paracetamol | |
ZA200109345B (en) | Method of enhancing insulin action. | |
ZA200006835B (en) | Novel insulin analogs with enhanced zinc binding. | |
ZA971250B (en) | Dental syringe. | |
AU4445201A (en) | Method for administering insulin to the buccal region | |
IL139218A0 (en) | 2-aroyl-4-acyl-paclitaxel (taxol) analogs | |
ZA200107275B (en) | Hypodermic injection system. |